MapLight Therapeutics Inc has filed a Form 4 with the US Securities and Exchange Commission, dated 28 July, according to Investing.com UK. The filing was reported on 29 July 2026.
Form 4 is typically used to report changes in the holdings of company insiders. No further details on the nature of the transaction or the insider involved were provided in the report.